Production and characterization of monoclonal antibodies against urea derivatives

A panel of monoclonal antibodies was generated against the ureabased haptenN-(2-N-chloroacetylaminobenzyl)-N′-4-chlorophenylurea as a tool for building up sensitive immune assays to detect urea derivatives and to screen them for catalytic antibodies (Abs). Eleven hybridomas were obtained that produced Abs reactive to the hapten. All Abs were of IgG class. Crossreactivities of the Abs to different haptens were examined, especially to a possible transition-state analog. Only four of the hybridomas (R2-DA10/F7, R2-GE7/H2, R2-HC2/A5, R2-HD6/F7) produced Abs crossreactive with the transition-state analog. From the 11 hybridomas, hybridoma B76-BF5 was chosen for further characterization. Compared to the other Abs, B76-BF5 showed the strongest binding and had a rather restricted specificity. These Abs could be used to build up a sensitive enzyme immunoassay for the detection of the hapten. All Abs were screened for crossreactivity with the pesticides monuron and diuron. No reactivity could be detected. In addition, the nucleotide sequences of the variable light and heavy chain genes of the similarly reactive Abs B76-BF5, B76-BB3, R2-DA10/F7, and R2-GA6/G3 were determined to clarify whether structure and binding specificity of these Abs showed any correlation.     

Generic microcystin immunoassay based on monoclonal antibodies against Adda.

A monoclonal antibody (clone AD4G2) was generated against a common part of microcystins and nodularins, the unusual amino acid Adda [(2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4E,6E-dienoic acid]. A direct competitive ELISA based on this antibody was developed and the cross-reactivity pattern was measured. Different toxins showed a very similar response. The assay provides therefore a sum parameter of microcystins, nodularins and peptide fragments containing Adda. The IC50 for microcystin-LR was 0.33 microg L(-1) which leads to a detection limit of 0.07 microg L(-1). This is well below the concentration of 1 microg L(-1) proposed by the World Health Organisation (WHO) as the limit for drinking water. Microcystin-LR spiked water samples in the concentration range between 0.1 and 1 microg L(-1) were measured and a mean recovery of 113+/-23% was found. The antibody is well suited for the determination of microcystins in drinking as well as surface water.     

Cell separations using targeted monoclonal antibodies against overproduced surface proteins

Applied Biochemistry and Biotechnology - The capacity of polystyrene microspheres with immobilized antibodies against type 1 pili ofE. coli was measured. Using pure IgG-type monoclonal antibodies...     

Purification of monoclonal antibodies against the low-density lipoprotein receptor by preparative isotachophoresis

A preparative free-flow isotachophoretic method for the purification of monoclonal antibodies from mouse ascites fluid and tissue culture media is described. This high-resolution method allows the direct separation of monoclonal antibodies from antibody-containing tissue culture media or ascites fluid and gives a better separation from the major contaminant protein fractions and a higher recovery of the monoclonal antibodies than anion-exchange chromatography. The purification can run continuously and without any time-consuming regeneration procedures; the monoclonal antibody is obtained under mild conditions in a small electrolyte volume.     

Production of monoclonal antibodies against a cell surface concanavalin A binding glycoprotein

Concanavalin A-binding (Con-A)-binding cell surface glycoproteins were isolated, via Con A-affinity chromatography, from Triton X-100-solubilized Chinese hamster ovary (CHO) cell plasma membranes. The Con A binding glycoproteins isolated in this manner displayed a significantly different profile on sodium dodecyl sulfate--polyacrylamide gels than did the Triton-soluble surface components, which were not retarded by the Con-A-Sepharose column. [125I]-Con A overlays of the pooled column fractions displayed on sodium dodecyl sulfate--polyacrylamide gel electro-phoresis (SDS-PAGE) demonstrated that there were virtually no Con A receptors associated with the unretarded peak released by the Con A-Sepharose column, whereas the material which was bound and specifically eluted from the Con A-Sepharose column with the sugar hapten alpha-methyl-D-mannopyranoside contained at least 15 prominent bands which bound [125I]-Con A. In order to produce monoclonal antibodies against various cell surface Con A receptors, Balb/c mice were immunized with the pooled Con A receptor fraction. Following immunization spleens were excised from the animals and single spleen cell suspensions were fused with mouse myeloma P3/X63-Ag8 cells. Numerous hybridoma clones were subsequently picked on the basis of their ability to secrete antibody which could bind to both live and glutaraldehyde-fixed CHO cells as well as to the Triton-soluble fraction isolated from the CHO plasma membrane fraction. Antibody from two of these clones was able to precipitate a single [125I]-labeled CHO surface component of approximately 265,000 daltons.     

Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis

A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of the human immunodeficiency virus. These epitopes are exposed during conformational changes when gp120 binds to its primary receptor CD4. Based on chemical modification of lysine and arginine residues followed by mass spectrometric analysis, we determined the epitope on gp120 recognized by the human monoclonal antibody 559/64-D, which was previously found to be specific for the CD4 binding domain. Twenty-four lysine and arginine residues in recombinant full-length glycosylated gp120 were characterized; the relative reactivities of two lysine residues and five arginine residues were affected by the binding of 559/64-D. The data show that the epitope is discontinuous and is located in the proximity of the CD4-binding site. Additionally, the reactivities of a residue that is located in the secondary receptor binding region and several residues distant from the CD4 binding site were also altered by Ab binding. These data suggest that binding of 559/64-D induced conformational changes which result in altered surface exposure of specific amino acids distant from the CD4-binding site. Consequently, binding of 559/64-D to gp120 affects not only the CD4-binding site, which is recognized as the epitope, but appears to have a global effect on surface exposed residues of the full-length glycosylated gp120.     

Production of monoclonal antibodies against fullerene C60 and development of a fullerene enzyme immunoassay

The aim of the present study was to produce monoclonal anti-fullerene C(60) antibodies and to develop the enzyme immunoassay for the detection in the first use of free fullerene C(60) both in solutions and in multicomponent biological probes. The immunization of mice with the conjugate of fullerene C(60) carboxylic derivative with thyroglobulin synthesized by carbodiimide activation led to the production of eight clones of anti-fullerene antibodies. The specificity of the antibody-fullerene binding was confirmed. Indirect competitive enzyme-linked immunosorbent assay (ELISA) was developed for the determination of water-soluble protein-conjugated fullerene, the fullerene aminocaproic acid, fullerenol and for pristine fullerene in solution. To solubilize extremely hydrophobic free fullerene C(60) a specially selected water-organic mixture compatible with immunoassay was proposed. The detection limit of free fullerene C(60) in solution was 2 μg L(-1). Fullerene C(60) was also detected by ELISA in organ homogenates of rats intraperitoneally or intragastrically administered with fullerene. To reduce the influence of biomatrices on the assay results a technique was developed for the biological sample pretreatment by the extraction of C(60) from bioprobe by toluene followed by the evaporation of toluene and dissolution of the fullerene-containing extract in the selected water-organic media. The ELISA procedure in the first use allowed the detection of fullerene C(60) in different tissues.     

Development of an enzyme-linked immunosorbent assay using specific monoclonal antibodies against theacrine and its application

Theacrine(1,3,7,9-tetramethyluric acid),a purine alkaloid similar to caffeine in its chemical structure,is isolated from edible Camellia assamica var.kucha and has various pharmacological activities including hypnotic effects,anti-depressant effects,anti-inflammatory and analgesic effects,and a protective effect against stress-provoked liver damage.A rapid and simple assay is required to quantify theacrine in biological samples for pharmacokinetic studies in small animals.This study aimed to establish an enzyme-linked immunosorbent assay(ELISA) for theacrine quantification in blood.Herein,we successfully obtained monoclonal antibodies(MAbs) against theacrine,MAbs C11B5,and developed an ELISA method for the fast determination of theacrine in mouse blood.The range for calibration of theacrine by ELISA was 0.156-100 μg mL~1.The half maximum inhibitory concentration(IC_(50)) value was1.55 μg mL~1.The ELISA method lays a good foundation for the further research.     

Molecular mapping of the immunologic surface of the hCG molecule by monoclonal antibodies (MCA)

Conclusion The 2-site IRMA-design with MCA is demonstrated to be superior over conventional l-site-RIA with polyclonal antibodies since it clearly distinguishes different molecular species of a hormone, especially hCG. Such parallel measurements are considered to be of diagnostic value for screening and therapeutic monitoring of tumor patients who produce free- and/or free-subunits early in the course of the disease, or exclusively throughout or in addition to holo-hCG.

---

Vermessung der immunologischen Oberfläche des hCG-Moleküls durch monoklonale Antikörper (MCA) —Entwicklung von 3 verschiedenen epitop-selektiven immunoradiometrischen Assays (IRMA) zur Messung von Holo-hCG und seinen freien Untereinheiten in normalen Individuen, Carcinom-Patienten und Carcinom-Zellkulturen

---

Supported by the Austrian Cancer Research Fund 1982/83 and in part by the Österreichische Fonds zur Förderung der wissenschaftlichen Forschung, P.4597, 1983     

Rational methods for predicting human monoclonal antibodies retention in protein A affinity chromatography and cation exchange chromatography. Structure-based chromatography design for monoclonal antibodies

Rational methods for predicting the chromatographic behavior of human monoclonal antibodies (hMabs) in protein A affinity chromatography and cation exchange chromatography from the amino acid sequences information were proposed. We investigated the relation between the structures of 28 hMabs and their chromatographic behavior in protein A affinity chromatography and cation exchange chromatography using linear gradient elution experiments. In protein A affinity chromatography, the elution pH of the hMabs was correlated with not only the structure of the Fc region (subclass), but also that of the variable region. The elution pH of hMabs that have LYLQMNSL sequences in between the CDR2 and CDR3 regions of the heavy chain became lower among the same subclass of hMabs. In cation exchange chromatography, the peak salt concentrations IR of hMabs that have the same sequences of variable regions (or that have a structural difference in their Fc region, which puts them into a subclass) were similar. The IR values of hMabs were well correlated with the equilibrium association constant Ke, and also with the surface positive charge distribution of the variable region of the heavy chain (corrected surface net positive charge (cN) of the VH region). Based on these findings, we developed rational methods for predicting the retention behavior, which were also tested with eight additional hMabs. By considering the information on the number of binding sites associated with protein adsorption as determined experimentally, and the surface positive charge distribution from the three-dimensional structure of Mab A, we hypothesized that hMabs is separated by cation exchange chromatography as the surface positive charge distribution of the VH region is recognized.     

Epitope mapping of monoclonal antibodies by mass spectrometry: Identification of protein antigens in complex biological systems

We describe the application of immunoaffinity extraction and mass spectrometry to the analysis of Ty1 Gag protein in lysates of Saccharomyces cerevisiae. A magnetic bead-conjugated monoclonal antibody was used to achieve selective extraction, the specificity of which was established by matrix-assisted laser desorption/ionization mass spectrometric (MS) analysis of an extract of the lysate of cells overexpressing the Ty1 Gag protein. MS analysis of similar extracts of lysates following tryptic hydrolysis confirmed selective extraction of the epitope-containing peptide fragment. Sufficient sensitivity was achieved to allow the application of this approach to the analysis of lysates of wild-type cells. Furthermore, the sequence of the epitope-containing peptide was confirmed by electrospray-tandem MS. To our knowledge, this constitutes the first report of the application of immunoaffinity extraction and tandem MS analysis to the characterization of an antigen recovered from a complex cellular system.     

Preparation of monoclonal antibodies against a derivative of semicarbazide as a metabolic target of nitrofurazone

Monoclonal antibodies (McAb) were produced to detect semicarbazide (SEM), a metabolite as a marker residue of nitrofurazone in animal food production. A carboxyphenyl derivative (CPSEM) of SEM was synthesized following derivatisation with 4-carboxybenzaldehyde (CBA). CPSEM was purified by recrystallization and conjugated to bovine serum albumin (BSA) or ovalbumin (OVA) as immunogen or coating antigen, respectively. Hybridomas were obtained by fusing mouse myeloma cells SP2/0 with splenocytes from the mice immunized with CPSEM-BSA. Hybridomas 1F10 and 4F2 secreting antibodies against CPSEM were obtained and subcloned. Ascites of monoclonal antibodies were prepared by injecting 1 × 10⁶ cells of hybridoma 1F10 into mice abdomen. McAb obtained from hybridoma 1F10 was highly specific for CPSEM and had no cross-reaction with various nitrofuran metabolites and a range of veterinary drugs. The sensitivity of the McAb to SEM was 0.01 ng mL⁻¹ and the IC₅₀ value was 1.3 ng mL⁻¹ (SEM in the form of CPSEM). McAb 1F10 is suitable to develop an immunoassay for SEM with sufficient sensitivity for monitoring nitrofurazone residues.